Gaia Healthcare was envisaged n conceptualized in 2016 to address unmet medical needs in Gulf Region with the aim of bringing cutting-edge products n services. The concept was initiated with an investment of 6 million USD in bringing a European model of techno-driven pharmaceutical distribution with as an initial investment with first mover advantage in the United Arab Emirates.
We are the largest vertically integrated pharmaceutical marketing & distribution company in the United Arab Emirates, with a cross-category ecosystem that covers In-licensing, Out-Licensing, Import, Registration, Marketing & Distribution of Pharmaceuticals in UAE & other Gulf countries through our distribution network.
Pioneering ground-breaking pharmaceutical distribution through connecting E-com technology with the best warehousing management systems coupled with the best logistics infrastructure including cold chain capabilities in UAE has allowed us to become the best player offering all the pharmaceutical distribution value chain under one umbrella.
It took a couple of years to become a significant player in pharmaceutical distribution in the United Arab Emirates, en route journey we invested in overseas manufacturing facilities, helping us acquire several marketing authorizations under our belt (MAHs).
In recent years, we combined our imagination and advances in pharma technology enabled us to bring Innovator Pharmaceuticals, several First to file Generics in different therapeutic segments like Pediatrics, Gynecology, Orthopedics, Cardiology, Diabetology for UAE & GCC countries.
Company History
GAIA Healthcare is a UAE healthcare company founded in 2016 with a vision to improve global healthcare by developing innovative and high-quality pharmaceutical products. They have focused on establishing a strong foundation of scientific research, rigorous quality standards, and a customer-centric approach. Their flagship product, Mention, revolutionized the treatment landscape for the therapeutic area and provided new hope to patients worldwide. They have invested in state-of-the-art manufacturing partners, research and development, and laboratories worldwide, and have weathered market challenges and embraced opportunities for growth. They are grateful for the support and trust bestowed upon them by healthcare professionals, patients, and stakeholders, as it has motivated them to push the boundaries of what is possible in healthcare.
2016
To expand its reach and serve a larger population, Gaia Healthcare DMCC started and bought 12 pharmacy chains, which allowed it to have a significant impact on the healthcare landscape.
2017
PDC is a fast-growing business entity from the Gaia Healthcare Group focused on transforming traditional 3PL logistics services to reduce supply chain, logistics & warehousing practices and costs. They are on a path to become a significant player in the 3PL sector in the GCC.
2018
We have achieved 90% coverage of the UAE pharmaceutical market, solidifying our position as a trusted partner.
2019
We have expanded our operations to a new state-of-the-art facility in Dubai Investment Park, enabling us to streamline operations and better serve customers.
2020
GAIA Healthcare established the Sales & Marketing Division to build brand awareness, nurture client relationships, and broaden market penetration. It will focus on strategic sales initiatives and creative marketing campaigns to fortify GAIA Healthcare’s position in the healthcare sector.
2021
GAIA Healthcare opens Scientific Office to advance healthcare.
2022
We have secured the local marketing authorization holder for innovative in-licensed pharmaceuticals, enabling us to provide healthcare professionals and patients with access to groundbreaking treatment options.
NOW
Gaia Healthcare has successfully registered a diverse range of at least 20 pharmaceutical and generic products in the UAE market. This achievement highlights their commitment to meeting the healthcare needs of the local population and delivering safe and effective medications. Gaia Healthcare is now poised for an exciting phase of expansion in the GCC region, allowing them to tap into new markets and make a positive impact on a larger scale. Their ambitious growth plans reflect their confidence in their products, commitment to excellence, and mission to be a leading player in the pharmaceutical industry.
